Sales Growth YoY (Last Twelve Months): Soleno Therapeutics Corp (SLNO)

Graphic logo of Soleno Therapeutics (SLNO)

Soleno Therapeutics (SLNO) ensures supply stability through a global warehouse network and strict quality control. The company's TTM annual revenue growth rate reflects current demand dynamics, with the current value equal to 0.00. Growth is based on synergy with clinics and patient alliances, although a narrow development pipeline creates the risk of a sharp price collapse in the event of regulatory failures.

Sales Growth YoY (Last Twelve Months): Soleno (SLNO) for 02/11/2024 - 05/30/2026

Summary analytical data breakdowns for Soleno Therapeutics Inc (SLNO)

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Analysis of all company metrics:Soleno Therapeutics
Mass-produced product of Soleno Therapeutics, Inc.

The market demonstrates full confidence in the leadership strategy of Soleno Therapeutics (SLNO) during its transition to drug commercialization. This metric measures the percentage change in revenue over a rolling year, allowing for an assessment of the business's actual expansion dynamics. By analyzing this TTM annual sales growth chart, an investor can determine the vector of the fundamental revenue trend. Steady growth in this indicator will confirm the biotech's successful adaptation to commercial sales.

Competitors of Soleno Therapeutics (SLNO)

Ascendis (ASND) - Trailing Twelve Months Revenue Growth|MDGL - Sales Growth YoY (Last Twelve Months)|CORT: Sales Growth YoY (Last Twelve Months)|RYTM: Sales Growth YoY (TTM)|AKRO - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Metsera Therapeutics|MoonLake Corp (MLTX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) crinetics.com (CRNX)|Revenue Growth YoY (Last 12 Months) newamsterdampharma.com NAMS|Sales Growth YoY (TTM) FOLD (amicusrx.com)|Annual Revenue Growth (Last Twelve Months) 89bio (ETNB)|Agios - Sales Growth YoY (TTM)|Structure Corp - Revenue Change YoY (Last 12 Months)|mimedx.com (MDXG) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Sales Growth RZLT (rezolutebio.com)|LXRX (Lexicon Pharmaceuticals Inc) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) MBX|Sales Growth YoY (Last Twelve Months) Altimmune Pharma (ALT)|Sales Growth YoY (Last Twelve Months) AARD (Aardvark Therapeutics Corp)|Sales Growth YoY (TTM) SGMT (Sagimet Biosciences, Inc.)|BioAge (BIOA) - Trailing Twelve Months Revenue Growth|BMEA: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) QNCX (Quince Therapeutics Inc)|GUTS (Fractyl) - Revenue Growth YoY (Last 12 Months)|vTv Therapeutics, Inc. - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Agape ATP Corp.|Revenue Growth YoY (Last 12 Months) Pluri (PLUR)|Sales Growth YoY (TTM) SYBX|Annual Revenue Growth (Last Twelve Months) Lipocine Inc|Sales Growth YoY (Last Twelve Months) Matinas BioPharma Holdings MTNB|Annual Revenue Growth (Last Twelve Months) Spruce Biosciences (SPRB)|GLTO: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth CTCX|LUMO (Lumos Pharma) - Revenue Growth YoY (Last 12 Months)|Sales Growth YoY (Last 12 Months) ONVO|RDUS (Radius Pharmaceuticals) - Sales Growth YoY (TTM)